Home / Health / Oryon Cell Therapies Secures $21M for Parkinson's Brain Repair
Oryon Cell Therapies Secures $21M for Parkinson's Brain Repair
23 Mar
Summary
- Oryon Cell Therapies emerged with $21 million in new funding.
- Early clinical data shows potential for brain function restoration.
- The company has raised a total of $42 million to date.
Oryon Cell Therapies has officially launched, securing $21 million in new funding on Monday. This latest financial injection brings the company's total funding to an impressive $42 million.
This funding supports the advancement of Oryon's experimental therapy, which has shown early clinical data indicating potential benefits for Parkinson's patients. The therapy aims to help restore lost brain function, offering a new avenue for treatment.
Researchers are optimistic about the therapy's prospects, as the early results suggest a positive impact on neurological function in individuals with Parkinson's disease.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
